MRI-based cerebrovascular reactivity is associated with cognitive function independent of Alzheimer disease pathology.
The use of genetic evaluation for suicidal ideation may represent a future application for precision medicine.
The heterogeneous expression of headache associated with COVID-19 indicates various underlying pathophysiological mechanisms.
The rates of severe acute respiratory syndrome coronavirus 2 infection are increased among minority and socioeconomically disadvantaged children.
Study authors compared the safety and efficacy of oral anticoagulants vs antiplatelets in patients with stroke and supracardiac atherosclerosis.
The FDA has accepted for Priority Review the Biologics License Application for aducanumab for the treatment of Alzheimer disease.
Weekly consults seen through a telestroke network decreased during the COVID-19 pandemic, with Black patients less likely to present with strokes.
The Lancet Commission added 3 new risk factors for dementia that coupled with the previous 9 lifestyle risk factors might prevent or delay up to 40% of dementias worldwide.
COVID-19 is associated with large vessel occlusion strokes.
Among health care providers in the New York City area, 13.7% have SARS-CoV-2 antibodies, a rate similar to adults randomly tested in New York state.
Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.
Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.
The ADVANCE study included 910 adults who experienced 4 to 14 migraines per month.
Annualized relapse rates are lower for patients with relapsing MS receiving anti-CD20 monoclonal antibody ofatumumab compared with teriflunomide.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.
Prescription drugs for the treatment of various sleep disorders including insomnia, narcolepsy, non-24-hour sleep disorder, and restless leg syndrome.
In some US States, a reduction was seen in the number of mechanical thrombectomy procedures performed for ischemic stroke in April 2020.
Researchers explored provider screening practices in primary care, women’s health, and well-child clinics to determine if barriers exist in meeting postpartum depression screening guidelines.